Chris LaVictoire Mahai, Director at abrdn Life Sciences Investors (HQL), bought 527 shares at $19.92 ($10K) on 2026-07-16, disclosed to the SEC on 2026-07-20.
Director Chris LaVictoire Mahai purchased 527 shares of abrdn Life Sciences Investors for $10,498, marking the largest purchase of his career. This significant insider buying activity may signal confidence in the asset manager's life sciences portfolio amidst a strong 1-year return.
The stock is currently trading at $16.37, representing a 21.26% gain over the past year and sitting 8.03% below its 52-week high of $17.80.
Insufficient data — needs manual review
Insufficient data — needs manual review
Something here stands out, but not much.
| Filing → |
| THW | BUY | 2026-07-20 | $11K | — | Filing → |
| MGU | BUY | 2006-09-27 | $10K | — | Filing → |